quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:06:32·111d
SECFiling
Cybin Inc. logo

SEC Form CERT filed by Cybin Inc.

CYBN· Cybin Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • CYBN
    Cybin Inc.
    Health Care

Recent analyst ratings

  • Mar 13UpdateGuggenheim$35.00
  • Nov 22UpdateHC Wainwright & Co.$10.00
  • Nov 19UpdateMaxim Group-
  • Oct 5UpdateOppenheimer$7.00
  • Aug 26UpdateCantor Fitzgerald$9.00

Related

  • SEC108d
    SEC Form 6-K filed by Cybin Inc.
  • PR108d
    HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq
  • SEC112d
    SEC Form 8-A12B filed by Cybin Inc.
  • SEC112d
    SEC Form 25 filed by Cybin Inc.
  • SEC113d
    SEC Form 6-K filed by Cybin Inc.
  • SEC114d
    SEC Form 6-K filed by Cybin Inc.
  • SEC114d
    SEC Form SUPPL filed by Cybin Inc.
  • PR114d
    Cybin Initiates At-The-Market Equity Program of up to US$100 Million
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022